Royalty Pharma (RPRX) News Today $36.10 -0.03 (-0.08%) Closing price 04:00 PM EasternExtended Trading$36.09 -0.01 (-0.03%) As of 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RPRX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Royalty Pharma PLC $RPRX Position Increased by Robeco Institutional Asset Management B.V.October 4 at 3:54 AM | marketbeat.comRoyalty Pharma PLC (NASDAQ:RPRX) Given Average Rating of "Buy" by AnalystsOctober 3, 2025 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Earns Buy Rating from Analysts at The Goldman Sachs GroupOctober 3, 2025 | americanbankingnews.comRoyalty Pharma (NASDAQ:RPRX) Upgraded by The Goldman Sachs Group to "Strong-Buy" RatingOctober 2, 2025 | marketbeat.comGoldman Sachs Initiates Coverage of Royalty Pharma (RPRX) with Buy RecommendationOctober 1, 2025 | msn.comRoyalty Pharma initiated with a Buy at Goldman SachsSeptember 30, 2025 | msn.comRoyalty Pharma appoints Ted Love as lead independent directorSeptember 29, 2025 | msn.comRoyalty Pharma Appoints Dr. Ted W. Love As Lead Independent DirectorSeptember 29, 2025 | globenewswire.comOverbrook Management Corp Trims Position in Royalty Pharma PLC $RPRXSeptember 29, 2025 | marketbeat.comAssessing Royalty Pharma (RPRX): Is the Recent Outperformance Reflected in Its Current Valuation?September 27, 2025 | finance.yahoo.comBank Pictet & Cie Europe AG Cuts Holdings in Royalty Pharma PLC $RPRXSeptember 27, 2025 | marketbeat.comRuffer LLP Makes New $6.41 Million Investment in Royalty Pharma PLC $RPRXSeptember 25, 2025 | marketbeat.comRoyalty Pharma plc (RPRX) Completes $2B Senior Notes Offering, Strengthens Capital for GrowthSeptember 24, 2025 | msn.comRoyalty Pharma plc (RPRX) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum TranscriptSeptember 23, 2025 | seekingalpha.comRidgewood Investments LLC Sells 11,236 Shares of Royalty Pharma PLC $RPRXSeptember 22, 2025 | marketbeat.comWedge Capital Management L L P NC Purchases 200,122 Shares of Royalty Pharma PLC $RPRXSeptember 21, 2025 | marketbeat.comMn Services Vermogensbeheer B.V. Purchases New Shares in Royalty Pharma PLC $RPRXSeptember 21, 2025 | marketbeat.comRoyalty Pharma to Present at Bernstein’s 2nd Annual Healthcare ForumSeptember 19, 2025 | markets.businessinsider.comRoyalty Pharma to Present at Bernstein's 2nd Annual Healthcare ForumSeptember 19, 2025 | globenewswire.comUBS Sticks to Their Hold Rating for Royalty Pharma (RPRX)September 17, 2025 | theglobeandmail.comTD Cowen Maintains a Buy on Royalty Pharma (RPRX)September 17, 2025 | insidermonkey.com1 Safe-and-Steady Stock with Promising Prospects and 2 We IgnoreSeptember 17, 2025 | finance.yahoo.comStrs Ohio Invests $1.89 Million in Royalty Pharma PLC $RPRXSeptember 17, 2025 | marketbeat.comRoyalty Pharma plc (RPRX) Reports 20% Portfolio Growth, Posts $727M in Q2 ReceiptsSeptember 16, 2025 | finance.yahoo.comPacific Capital Partners Ltd Cuts Holdings in Royalty Pharma PLC $RPRXSeptember 16, 2025 | marketbeat.comUBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Increases Stock Position in Royalty Pharma PLC $RPRXSeptember 15, 2025 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Downgraded to Hold Rating by Wall Street ZenSeptember 15, 2025 | marketbeat.comEmpowered Funds LLC Makes New $8.01 Million Investment in Royalty Pharma PLC $RPRXSeptember 13, 2025 | marketbeat.comRoyalty Pharma: Investor Day UpsideSeptember 12, 2025 | seekingalpha.comPetrus Trust Company LTA Makes New $227,000 Investment in Royalty Pharma PLC $RPRXSeptember 12, 2025 | marketbeat.comEP Wealth Advisors LLC Takes $242,000 Position in Royalty Pharma PLC $RPRXSeptember 12, 2025 | marketbeat.comRoyalty Pharma Plc (RPRX) Investor Day 2025 Call (Transcript)September 11, 2025 | seekingalpha.comRoyalty Pharma Plc (RPRX) Investor Day 2025 TranscriptSeptember 11, 2025 | seekingalpha.comRoyalty Pharma ‘on track’ to deliver portfolio receipts of $4.7B by 2030September 11, 2025 | msn.comRoyalty Pharma Investor Day Highlights Strong Growth Outlook and Company’s Plans to Drive Value CreationSeptember 11, 2025 | markets.businessinsider.comRoyalty Pharma plc (RPRX) Commits $300M to Zenas’ Obexelimab ProgramSeptember 11, 2025 | finance.yahoo.comRoyalty Pharma plc (RPRX) Analyst/Investor Day - SlideshowSeptember 11, 2025 | seekingalpha.comRoyalty Pharma Investor Day Highlights Strong Growth Outlook and Company's Plans to Drive Value CreationSeptember 11, 2025 | globenewswire.comUSS Investment Management Ltd Decreases Stock Holdings in Royalty Pharma PLC $RPRXSeptember 11, 2025 | marketbeat.comRoyalty Pharma Scores Relative Strength Rating Upgrade; Hits Key ThresholdSeptember 10, 2025 | msn.comRoyalty Pharma Announces Release of Deloitte’s Report on the Biopharma Royalty MarketSeptember 10, 2025 | markets.businessinsider.comRoyalty Pharma Announces Release of Deloitte's Report on the Biopharma Royalty MarketSeptember 10, 2025 | globenewswire.comRoyalty Pharma PLC $RPRX Shares Acquired by Uniplan Investment Counsel Inc.September 10, 2025 | marketbeat.comAlliancebernstein L.P. Acquires 86,873 Shares of Royalty Pharma PLC $RPRXSeptember 10, 2025 | marketbeat.com1 Mid-Cap Stock with Exciting Potential and 2 Facing ChallengesSeptember 9, 2025 | finance.yahoo.comRoyalty Pharma Plc (RPRX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 9, 2025 | seekingalpha.comAmundi Sells 1,316,620 Shares of Royalty Pharma PLC $RPRXSeptember 9, 2025 | marketbeat.comBaird Financial Group Inc. Has $1.59 Million Position in Royalty Pharma PLC $RPRXSeptember 9, 2025 | marketbeat.comPunch & Associates Investment Management Inc. Increases Holdings in Royalty Pharma PLC $RPRXSeptember 8, 2025 | marketbeat.comRoyalty Pharma PLC $RPRX Shares Purchased by AQR Capital Management LLCSeptember 8, 2025 | marketbeat.com Get Royalty Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RPRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RPRX Media Mentions By Week RPRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RPRX News Sentiment▼0.650.54▲Average Medical News Sentiment RPRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RPRX Articles This Week▼612▲RPRX Articles Average Week Get the Latest News and Ratings for RPRX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Royalty Pharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Zoetis News Today Corcept Therapeutics News Today Jazz Pharmaceuticals News Today Perrigo News Today Supernus Pharmaceuticals News Today Nektar Therapeutics News Today Pacira BioSciences News Today Omeros News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RPRX) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Royalty Pharma PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Royalty Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
